- Home
- KALV vs SLI Comparison
KALV vs SLI Comparison
Compare KALV & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- SLI
- Stock Information
- Founded
- KALV N/A
- SLI 1998
- Country
- KALV United States
- SLI Canada
- Employees
- KALV N/A
- SLI N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- SLI Major Chemicals
- Sector
- KALV Health Care
- SLI Industrials
- Exchange
- KALV Nasdaq
- SLI Nasdaq
- Market Cap
- KALV 418.1M
- SLI 406.1M
- IPO Year
- KALV N/A
- SLI N/A
- Fundamental
- Price
- KALV $8.36
- SLI $1.47
- Analyst Decision
- KALV Strong Buy
- SLI Strong Buy
- Analyst Count
- KALV 6
- SLI 2
- Target Price
- KALV $26.25
- SLI $3.95
- AVG Volume (30 Days)
- KALV 421.6K
- SLI 1.4M
- Earning Date
- KALV 12-31-2024
- SLI 02-06-2025
- Dividend Yield
- KALV N/A
- SLI N/A
- EPS Growth
- KALV N/A
- SLI N/A
- EPS
- KALV N/A
- SLI 0.61
- Revenue
- KALV N/A
- SLI N/A
- Revenue This Year
- KALV N/A
- SLI N/A
- Revenue Next Year
- KALV N/A
- SLI N/A
- P/E Ratio
- KALV N/A
- SLI $2.35
- Revenue Growth
- KALV N/A
- SLI N/A
- 52 Week Low
- KALV $7.98
- SLI $1.05
- 52 Week High
- KALV $16.88
- SLI $2.64
- Technical
- Relative Strength Index (RSI)
- KALV 36.75
- SLI 38.62
- Support Level
- KALV $8.48
- SLI $1.34
- Resistance Level
- KALV $9.30
- SLI $1.49
- Average True Range (ATR)
- KALV 0.65
- SLI 0.10
- MACD
- KALV -0.06
- SLI -0.01
- Stochastic Oscillator
- KALV 17.12
- SLI 29.40
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, Tetra Project, and Bristol Dry Lake Project.